A Multi-centre Randomised Double Blind Placebo Controlled Study Comparing Two Regimens of Combination Therapy in Early DMARD Naive Rheumatoid Arthritis.

Trial Profile

A Multi-centre Randomised Double Blind Placebo Controlled Study Comparing Two Regimens of Combination Therapy in Early DMARD Naive Rheumatoid Arthritis.

Completed
Phase of Trial: Phase III

Latest Information Update: 14 May 2018

At a glance

  • Drugs Infliximab (Primary) ; Methotrexate; Methylprednisolone; Methylprednisolone
  • Indications Rheumatoid arthritis
  • Focus Biomarker; Pharmacodynamics; Therapeutic Use
  • Acronyms IDEA
  • Most Recent Events

    • 14 May 2018 Last checked against ClinicalTrials.gov record.
    • 16 Sep 2016 Results of a cardiovascular substudy (n=79) published in the Rheumatology
    • 29 Oct 2013 Results of the cardiovascular analysis (n=79) presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top